Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Sen. Widen hears local officials on detection devices, urges federal help to beat new synthetic opioid threats

Senate Committee on Finance · May 9, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Sen. Widen convened law enforcement, public-health and treatment providers to discuss handheld mass spectrometers and test strips as early-warning tools for emerging synthetic opioids; speakers described current lab lags, estimated device costs (~$95,000), and a $380,000 congressional request to buy four more machines for statewide coverage.

Senator Widen convened a briefing with local law enforcement, public-health officials and treatment providers to discuss early-warning detection for an emerging class of synthetic opioids — variously referred to during the meeting as “nitazines,” “nidazines,” or similar spellings — and urged federal support for field-deployable testing equipment.

Widen opened the session by calling the new class of compounds a major threat and saying the response must balance “firm punishment for drug dealers and compassionate treatment for those who are suffering from addiction.” He asked participants for practical steps federal and local partners can take to avoid repeating mistakes made during the spread of fentanyl.

Chris Gibson, executive director of the Oregon-Idaho High Intensive Drug Tra (self-identified), and…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans